Dudediligence.

Yarrow Bioscience, Inc

YARWNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$98,000Mar ’24$198,000Jun ’24$121,000Sep ’24$84,000Dec ’24$202,000Mar ’25$69,000Jun ’25$86,000Mar ’26$97,000Jun ’26
Net income, by quarter
−$6.2MMar ’24−$9.4MJun ’24−$12.2MSep ’24−$12.0MDec ’24−$8.6MMar ’25−$5.8MJun ’25−$3.6MMar ’26−$3.0MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$931,000$477,000$424,000$501,000$570,000
Gross profit−$2.4Mnone on filenone on filenone on filenone on file
Operating income−$38.9M−$34.3M−$29.3M−$43.6M−$29.7M
Net income−$73.3M−$23.2M−$28.5M−$39.8M−$26.5M
Operating cash flow−$56.4M−$29.2M−$25.3M−$34.0M−$33.1M
Free cash flow−$56.4Mnone on file−$25.3M−$34.1M−$33.1M
Cash$42.3M$30.9M$30.6M$19.9M$24.0M
Debt$0.00$0.00$0.00$0.00$0.00
Shares outstanding3.0M3.2M14.1M14.8M33.3M